Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 837, pseudogene (RNU6-837P) is a processed pseudogene belonging to the family of U6 small nuclear RNA (snRNA) genes. U6 snRNA is an essential component of the spliceosome, catalyzing pre-mRNA splicing in eukaryotes; however, RNU6-837P itself does not code for functional RNA or protein. The human genome contains many U6-derived pseudogenes, which typically arise from duplication or retrotransposition events and are generally transcriptionally silent. There is no evidence that RNU6-837P acts as a receptor, enzyme, or signaling protein; it is not a therapeutic target nor associated with disease phenotypes, drugs, or regulatory activity. The canonical U6 snRNA gene (not this pseudogene) is highly conserved across species and is essential for cell viability due to its role in splicing, but the pseudogene copy RNU6-837P does not have established molecular or clinical significance.
None (not a drug target)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 837, pseudogene (RNU6-837P).